NDUFB6 and B-cell chronic lymphocytic leukemia: IACS-010759 is a small molecule (Figure 1) that was originally reported in 2018 as an agent that suppresses oxidative phosphorylation (OXPHOS) in chronic lymphocytic leukemia (CLL) cells by targeting mitochondrial respiratory complex I (CI), thereby promoting glycolysis [2].